![Henrik Bergentoft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henrik Bergentoft
Finanzdirektor/CFO bei
ONCOPEPTIDES AB
Vermögen: 4 930 $ am 31.08.2026
Profil
Henrik Bergentoft is currently the Chief Financial Officer at Oncopeptides AB. He previously worked as the Finance Director at Aerocrine AB from 2014 to 2016.
Henrik also held the position of Controller at Autoliv, Inc. Additionally, he served as the Chief Financial Officer at C-RAD AB from 2020 to 2022, at ContextVision AB from 2007 to 2009, at Melker Schörling AB from 2016 to 2020, at RaySearch Laboratories AB from 2022 to 2023, and at Micro Systemation AB from 2016 to 2020.
Prior to that, Henrik was the Chief Financial Officer at House of Friends AB from 2009 to 2014.
He started his career as an Accountant at Andersen Sweden and Deloitte AB (Sweden).
Henrik obtained an MBA from the University of Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCOPEPTIDES AB 0,01 % | 31.12.2024 | 24.751 ( 0,01 % ) | 4 930 $ | 31.08.2026 |
Aktive Positionen von Henrik Bergentoft
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOPEPTIDES AB | Finanzdirektor/CFO | 13.11.2023 |
Ehemalige bekannte Positionen von Henrik Bergentoft
| Unternehmen | Position | Ende |
|---|---|---|
| RAYSEARCH LABORATORIES AB | Finanzdirektor/CFO | 07.07.2023 |
| C-RAD AB | Finanzdirektor/CFO | 11.11.2022 |
| MELKER SCHORLING AB | Finanzdirektor/CFO | 01.02.2020 |
| MICRO SYSTEMATION AB | Finanzdirektor/CFO | 31.01.2020 |
| AEROCRINE AB | Finanzdirektor/CFO | 01.07.2016 |
Ausbildung von Henrik Bergentoft
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Autoliv, Inc.
 Autoliv, Inc. Auto Parts: OEMProducer Manufacturing Develops, manufactures and supplies passive safety systems to the automotive industry | Producer Manufacturing |
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients | Electronic Technology |
C-RAD AB
 C-RAD AB Medical SpecialtiesHealth Technology Engages in the management and marketing of its subsidiaries products and solutions for radiation therapy | Health Technology |
ContextVision AB
 ContextVision AB Packaged SoftwareTechnology Services Develops image analysis and medical applications | Technology Services |
Melker Schörling AB
 Melker Schörling AB Investment ManagersFinance Melker Schörling invests in both public and private companies located in Scandinavia. The firm focuses on the industrial sector. It participates in buyout transactions. | Finance |
RaySearch Laboratories AB
 RaySearch Laboratories AB Packaged SoftwareTechnology Services Supplies computer software that improves the efficacy of radiation therapy for cancer | Technology Services |
Deloitte AB (Sweden)
 Deloitte AB (Sweden) Miscellaneous Commercial ServicesCommercial Services Provides accounting and payroll services | Commercial Services |
Andersen Sweden
 Andersen Sweden Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Micro Systemation AB
 Micro Systemation AB Packaged SoftwareTechnology Services Engages in mobile phone forensic examinations | Technology Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
House of Friends AB
 House of Friends AB Advertising/Marketing ServicesCommercial Services Provides digital and traditional communication solutions | Commercial Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
